Department of Radiation Oncology, New York University School of Medicine, New York, USA.
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):379-84. doi: 10.1016/j.ijrobp.2009.07.1695. Epub 2009 Dec 16.
To compare temporal lobe dose delivered by three pituitary macroadenoma irradiation techniques: three-field three-dimensional conformal radiotherapy (3D-CRT), three-field intensity-modulated radiotherapy (3F IMRT), and a proposed novel alternative of five-field IMRT (5F IMRT).
Computed tomography-based external beam radiotherapy planning was performed for 15 pituitary macroadenoma patients treated at New York University between 2002 and 2007 using: 3D-CRT (two lateral, one midline superior anterior oblique [SAO] beams), 3F IMRT (same beam angles), and 5F IMRT (same beam angles with additional right SAO and left SAO beams). Prescription dose was 45 Gy. Target volumes were: gross tumor volume (GTV) = macroadenoma, clinical target volume (CTV) = GTV, and planning target volume = CTV + 0.5 cm. Structure contouring was performed by two radiation oncologists guided by an expert neuroradiologist.
Five-field IMRT yielded significantly decreased temporal lobe dose delivery compared with 3D-CRT and 3F IMRT. Temporal lobe sparing with 5F IMRT was most pronounced at intermediate doses: mean V25Gy (% of total temporal lobe volume receiving ≥25 Gy) of 13% vs. 28% vs. 29% for right temporal lobe and 14% vs. 29% vs. 30% for left temporal lobe for 5F IMRT, 3D-CRT, and 3F IMRT, respectively (p < 10(-7) for 5F IMRT vs. 3D-CRT and 5F IMRT vs. 3F IMRT). Five-field IMRT plans did not compromise target coverage, exceed normal tissue dose constraints, or increase estimated brain integral dose.
Five-field IMRT irradiation technique results in a statistically significant decrease in the dose to the temporal lobes and may thus help prevent neurocognitive sequelae in irradiated pituitary macroadenoma patients.
比较三种垂体大腺瘤照射技术(三维适形放疗[3D-CRT]、三野强度调制放疗[3F-IMRT]和一种新的五野 IMRT 替代方法[5F-IMRT])所给予的颞叶剂量。
2002 年至 2007 年,纽约大学的 15 例垂体大腺瘤患者接受了基于 CT 的外照射放疗计划,方法如下:3D-CRT(两个外侧野,一个中线前上方野)、3F-IMRT(相同的射野角度)和 5F-IMRT(相同的射野角度,外加右侧前上方野和左侧前上方野)。处方剂量为 45 Gy。靶区包括:大体肿瘤体积(GTV)=大腺瘤、临床靶区(CTV)=GTV、计划靶区=CTV+0.5 cm。两位放射肿瘤学家在一位神经放射学专家的指导下进行了结构勾画。
5F-IMRT 与 3D-CRT 和 3F-IMRT 相比,显著降低了颞叶剂量。5F-IMRT 对颞叶的保护作用在中等剂量时最为明显:右侧颞叶的平均 V25Gy(接受≥25 Gy 剂量的颞叶总容积百分比)分别为 13%、28%和 29%,左侧颞叶分别为 14%、29%和 30%,分别为 5F-IMRT、3D-CRT 和 3F-IMRT(5F-IMRT 与 3D-CRT 相比和 5F-IMRT 与 3F-IMRT 相比,p<10(-7))。5F-IMRT 计划并未降低靶区覆盖率、超过正常组织剂量限制或增加估计的脑积分剂量。
5F-IMRT 照射技术可显著降低颞叶剂量,从而可能有助于预防接受放疗的垂体大腺瘤患者的神经认知后遗症。